<DOC>
	<DOCNO>NCT02885168</DOCNO>
	<brief_summary>The purpose demonstrate vasoreactivity patient septic shock evaluate dose-response curve diminish septic shock ameliorate activated protein C ( APC ) . This amelioration correlate decrease inflammation , decrease reactive oxygen specie ( ROS ) marker increase circulate catecholamine .</brief_summary>
	<brief_title>Modulation Vasoreactivity Septic Shock : Impact Recombinant Protein C</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Phenylephrine</mesh_term>
	<mesh_term>Oxymetazoline</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<criteria>Patients septic shock determine standard criterion ( include infection severe infection ) Pregnant woman Absence sign informed consent . Due gravity medical situation patient , inclusion possible informed consent family member . As soon possible , informed consent obtain patient Contraindication Xigris : evolutive internal bleeding , intracranial pathology , neoplasia brain involvement , concomitant heparin therapy &gt; = 15 IU/kg/h , know hemorrhagic diathesis except acute coagulopathy subsequent sepsis , severe chronic liver disease , platelet count &lt; 30000 x 10^6/L , high bleeding risk , know hypersensibility drotrecogin alfa ( activate ) , one excipients bovine thrombin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>vasoreactivity</keyword>
	<keyword>recombinant activate protein C</keyword>
</DOC>